MODIFICATION
A -- Synthesis and Distribution of Drugs of Abuse and Related Compounds
- Notice Date
- 2/13/2013
- Notice Type
- Modification/Amendment
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- N01DA-13-7784
- Archive Date
- 4/5/2013
- Point of Contact
- Ryan Cleary, Phone: (301)443-6677, Kenneth E Goodling, Phone: (301)443-6677
- E-Mail Address
-
clearyrc@mail.nih.gov, kg25d@nih.gov
(clearyrc@mail.nih.gov, kg25d@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The National Institute on Drug Abuse intends to solicit proposals from qualified organizations (NAICS Code 541712) having the capability to: (1) acquire, synthesize, and store several unlabeled, radio-labeled, and deuterium labeled drugs of abuse and related chemical compounds in the NIDA drug supply inventory and distribute them to research investigators upon NIDA approval; (2) check the purity and stability of these compounds as necessary and produce and update their respective data sheets; (3) replenish and continue to replete existing drug supply inventory with depleted drugs/compounds; (4) identify, acquire, and update the drug supply inventory (research resources/catalog) with newly discovered chemical compounds useful for drug abuse research; and (5) use, maintain, and update the NIDA drug supply data base, Drug Inventory Supply & Control System (DISCS). In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances. We anticipate that one (1) indefinite delivery, indefinite quantity (IDIQ), task order contract will be awarded for a period of performance of five years. NIDA may award either cost reimbursement and/or fixed price task orders under this contract. NIDA anticipates that at least one task order will be awarded with the contract. RFP No. N01DA-13-7784 will be available electronically on or about February 4, 2013. You can access the RFP through the FedBizOpps (URL: http://fedbizopps.gov) or through the NIDA website: (URL: http://www.drugabuse.gov/funding/funding-opportunities/nida-requests-contract-proposals-rfps). All information required for the submission of a proposal will be contained in or accessible through the RFP package. Responses to the RFP will be due on or about March 21, 2013. NIDA will consider proposals submitted by any responsible offeror. Based upon market research, the Government is not using the policies contained in Part 12, Acquisition of Commercial Items, in its solicitation for the described supplies or services. However, interested persons may identify to the Contracting Officer their interest and capability to satisfy the Government's requirement with a commercial item within 15 days of this notice. This advertisement does not commit the Government to award a contract.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-13-7784/listing.html)
- Record
- SN02986790-W 20130215/130213234328-e339c5b4567455bb7fd463e71648316b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |